Lichenoid proliferative leukoplakia, lichenoid lesions with evolution to proliferative leukoplakia or a continuum of the same precancerous condition? A revised hypothesis.


Journal

Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
ISSN: 1600-0714
Titre abrégé: J Oral Pathol Med
Pays: Denmark
ID NLM: 8911934

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 03 11 2020
accepted: 05 11 2020
pubmed: 24 11 2020
medline: 13 2 2021
entrez: 23 11 2020
Statut: ppublish

Résumé

Multiple white plaques of the oral mucosa are usually associated with potentially malignant disorders such as oral lichen planus, oral lichenoid lesions and proliferative verrucous leukoplakia. Previous studies in the current literature describe a potential clinical overlap in these entities. The aim of this study is to review clinicopathological and evolutive features of these Oral Potentially Malignant Disorders highlighting the dynamic changes of diagnoses. It was previously hypothesized that a subset of patients with oral lichen planus or oral lichenoid diagnosis, could develop multiple white plaques during the natural history of the disease, fulfilling diagnostic criteria for proliferative verrucous leukoplakia. Consequently, these entities could, under certain conditions, obey a continuum of the same precancerous condition in the context of the field cancerization theory, increasing the risk of malignant transformation. Nevertheless, there is limited scientific evidence concerning this issue. Further studies are needed to understand the biological and evolutive features of the link between these oral potentially malignant disorders. Regardless of its diagnosis, these patients with multifocal white lesions must be carefully monitored to detect early malignant transformation.

Sections du résumé

BACKGROUND BACKGROUND
Multiple white plaques of the oral mucosa are usually associated with potentially malignant disorders such as oral lichen planus, oral lichenoid lesions and proliferative verrucous leukoplakia. Previous studies in the current literature describe a potential clinical overlap in these entities. The aim of this study is to review clinicopathological and evolutive features of these Oral Potentially Malignant Disorders highlighting the dynamic changes of diagnoses.
DISCUSSION CONCLUSIONS
It was previously hypothesized that a subset of patients with oral lichen planus or oral lichenoid diagnosis, could develop multiple white plaques during the natural history of the disease, fulfilling diagnostic criteria for proliferative verrucous leukoplakia. Consequently, these entities could, under certain conditions, obey a continuum of the same precancerous condition in the context of the field cancerization theory, increasing the risk of malignant transformation. Nevertheless, there is limited scientific evidence concerning this issue.
CONCLUSION CONCLUSIONS
Further studies are needed to understand the biological and evolutive features of the link between these oral potentially malignant disorders. Regardless of its diagnosis, these patients with multifocal white lesions must be carefully monitored to detect early malignant transformation.

Identifiants

pubmed: 33225541
doi: 10.1111/jop.13133
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

129-135

Informations de copyright

© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Warnakulasuriya S, Kujan O, Aguirre-Urizar J, Bagan J, González-Moles M, Kerr AR, Lodi G, Mello FW, Monteiro L, Ogden GR, Sloan P, Johnson NW. Oral potentially malignant disorders: A consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer. Oral Diseases. 2020. http://dx.doi.org/10.1111/odi.13704
Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007;36:575-580. https://doi.org/10.1111/j.1600-0714.2007.00582.x
Warnakulasuriya S. Clinical features and presentation of oral potentially malignant disorders. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125:582-590. https://doi.org/10.1016/j.oooo.2018.03.011
Aguirre-Urizar JM. Proliferative multifocal leukoplakia better name that proliferative verrucous leukoplakia. World J Surg Oncol. 2011;9:122. https://doi.org/10.1186/1477-7819-9-122
Hansen LS, Olson JA, Silverman S. Proliferative verrucous leukoplakia. A long-term study of thirty patients. Oral Surg Oral Med Oral Pathol. 1985;60:285-298.
Cerero-Lapiedra R, Baladé-Martínez D, Moreno-López L-A, Esparza-Gómez G, Bagán JV. Proliferative verrucous leukoplakia: a proposal for diagnostic criteria. Med Oral Patol Oral Cir Bucal. 2010;15:e839-845.
Villa A, Menon RS, Kerr AR, et al. Proliferative leukoplakia: proposed new clinical diagnostic criteria. Oral Dis. 2018;24:749-760. https://doi.org/10.1111/odi.12830
Palefsky JM, Silverman S, Abdel-Salaam M, Daniels TE, Greenspan JS. Association between proliferative verrucous leukoplakia and infection with human papillomavirus type 16. J Oral Pathol Med. 1995;24:193-197. https://doi.org/10.1111/j.1600-0714.1995.tb01165.x
Lopes MA, Feio P, Santos-Silva AR, Vargas PA. Proliferative verrucous leukoplakia may initially mimic lichenoid reactions. World J Clin Cases. 2015;3:861-863. https://doi.org/10.12998/wjcc.v3.i10.861
Garcia-Pola M-J, Llorente-Pendás S, González-Garcia M, García-Martín J-M. The development of proliferative verrucous leukoplakia in oral lichen planus. A preliminary study. Med Oral Patol Oral Cir Bucal. 2016;21:e328-e334.
Eisen D, Carrozzo M, Bagan Sebastian J-V, Thongprasom K. Number V Oral lichen planus: clinical features and management. Oral Dis. 2005;11:338-349. https://doi.org/10.1111/j.1601-0825.2005.01142.x
Bagan JV, Jimenez Y, Sanchis JM, et al. Proliferative verrucous leukoplakia: high incidence of gingival squamous cell carcinoma. J Oral Pathol Med. 2003;32:379-382.
Warnakulasuriya S. Oral potentially malignant disorders: a comprehensive review on clinical aspects and management. Oral Oncol. 2020;102:e104550. https://doi.org/10.1016/j.oraloncology.2019.104550
Speight PM, Khurram SA, Kujan O. Oral potentially malignant disorders: risk of progression to malignancy. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125:612-627. https://doi.org/10.1016/j.oooo.2017.12.011
Piemonte ED, Lazos JP, Brunotto M. Relationship between chronic trauma of the oral mucosa, oral potentially malignant disorders and oral cancer. J Oral Pathol Med. 2010;39:513-517. https://doi.org/10.1111/j.1600-0714.2010.00901.x
Roosaar A, Yin L, Sandborgh-Englund G, Nyrén O, Axéll T. On the natural course of oral lichen lesions in a Swedish population-based sample. J Oral Pathol Med. 2006;35:257-261. https://doi.org/10.1111/j.1600-0714.2006.00420.x
Batsakis JG, Suarez P, El-Naggar AK. Proliferative verrucous leukoplakia and its related lesions. Oral Oncol. 1999;35(4):354-359. https://doi.org/10.1016/s1368-8375(99)00007-x
Pentenero M, Meleti M, Vescovi P, Gandolfo S. Oral proliferative verrucous leucoplakia: are there particular features for such an ambiguous entity? A systematic review. Br J Dermatol. 2014;170:1039-1047. https://doi.org/10.1111/bjd.12853
Guan G, Mei L, Polonowita A, Hussaini H, Seo B, Rich AM. Malignant transformation in oral lichen planus and lichenoid lesions: a 14-year longitudinal retrospective cohort study of 829 patients in New Zealand. Oral Surg Oral Med Oral Pathol Oral Radiol. 2020;130:411-418. https://doi.org/10.1016/j.oooo.2020.07.002
Cortés-Ramírez D-A, Gainza-Cirauqui M-L, Echebarria-Goikouria M-A, Aguirre-Urizar JM. Oral lichenoid disease as a premalignant condition: the controversies and the unknown. Med Oral Patol Oral Cir Bucal. 2009;14:E118-E122.
Kaplan I, Ventura-Sharabi Y, Gal G, Calderon S, Anavi Y. The dynamics of oral lichen planus: a retrospective clinicopathological study. Head Neck Pathol. 2011;6:178-183. https://doi.org/10.1007/s12105-011-0318-3
Fernandes D-T, Santos-Silva A-R, Vargas P-A, Lopes M-A. Letter to the Editor: development of proliferative verrucous leukoplakia (PVL) in oral lichen planus: Is it not a clinical spectrum of PVL? Med Oral Patol Oral Cir Bucal. 2017;22:e142-e143. https://doi.org/10.4317/medoral.21605
Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646-674. https://doi.org/10.1016/j.cell.2011.02.013
Müller S. Oral manifestations of dermatologic disease: a focus on lichenoid lesions. Head and Neck Pathol. 2011;5:36-40. https://doi.org/10.1007/s12105-010-0237-8
Fitzpatrick SG, Honda KS, Sattar A, Hirsch SA. Histologic lichenoid features in oral dysplasia and squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;117:511-520. https://doi.org/10.1016/j.oooo.2013.12.413
Davidova LA, Fitzpatrick SG, Bhattacharyya I, Cohen DM, Islam MN. Lichenoid characteristics in premalignant verrucous lesions and verrucous carcinoma of the oral cavity. Head Neck Pathol. 2019;13:573-579. https://doi.org/10.1007/s12105-019-01006-4
Axéll T. Hypersensitivity of the oral mucosa: clinics and pathology. Acta Odontol Scand. 2001;59:315-319. https://doi.org/10.1080/000163501750541192
Georgakopoulou EA. Cinnamon contact stomatitis. J Dermatol Case Rep. 2010;4:28-29. https://doi.org/10.3315/jdcr.2010.1047
Chainani-Wu N, Purnell DM, Silverman S. Oral leukoplakia development in patients with pre-existing oral lichen planus. J Calif Dent Assoc. 2015;43:35-39.
Ragaz A, Ackerman AB. Evolution, maturation, and regression of lesions of lichen planus. New observations and correlations of clinical and histologic findings. Am J Dermatopathol. 1981;3(1):5-26. https://doi.org/10.1097/00000372-198100310-00002
Aguirre-Urizar J-M, Alberdi-Navarro J, Lafuente-Ibáñez de Mendoza I, et al. Clinicopathological and prognostic characterization of oral lichenoid disease and its main subtypes: A series of 384 cases. Med Oral Patol Oral Cir Bucal. 2020;25(4):e554-e562. https://doi.org/10.4317/medoral.23576
van der Waal I. Oral lichen planus and oral lichenoid lesions; a critical appraisal with emphasis on the diagnostic aspects. Med Oral Patol Oral Cir Bucal. 2009;14:E310-E314.
Aguirre Urizar JM. Letter to the editor: oral lichenoid disease. A new classification proposal. Med Oral Patol Oral Cir Bucal. 2008;13:E224.
Al-Hashimi I, Schifter M, Lockhart PB, et al. Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103:S25.e1-S25.e12. https://doi.org/10.1016/j.tripleo.2006.11.001
Eisen D. The clinical features, malignant potential, and systemic associations of oral lichen planus: a study of 723 patients. J Am Acad Dermatol. 2002;46:207-214. https://doi.org/10.1067/mjd.2002.120452
González-Moles MÁ, Ruiz-Ávila I, González-Ruiz L, Ayén Á, Gil-Montoya JA, Ramos-García P. Malignant transformation risk of oral lichen planus: a systematic review and comprehensive meta-analysis. Oral Oncol. 2019;96:121-130. https://doi.org/10.1016/j.oraloncology.2019.07.012
Thomson PJ, Goodson ML, Smith DR. Potentially malignant disorders revisited-The lichenoid lesion/proliferative verrucous leukoplakia conundrum. J Oral Pathol Med. 2018;47:557-565. https://doi.org/10.1111/jop.12716
Bagán JV, Murillo J, Poveda R, Gavaldá C, Jiménez Y, Scully C. Proliferative verrucous leukoplakia: unusual locations of oral squamous cell carcinomas, and field cancerization as shown by the appearance of multiple OSCCs. Oral Oncol. 2004;40:440-443. https://doi.org/10.1016/j.oraloncology.2003.10.008
Mignogna MD, Fedele S, Lo Russo L, Mignogna C, de Rosa G, Porter SR. Field cancerization in oral lichen planus. European J Surg Oncol (EJSO). 2007;33:383-389. https://doi.org/10.1016/j.ejso.2006.09.028

Auteurs

Gerardo Gilligan (G)

Oral Medicine Department, Facultad de Odontología, Universidad Nacional de Córdoba, Córdoba, Argentina.

Federico Garola (F)

Oral Medicine Department, Facultad de Odontología, Universidad Nacional de Córdoba, Córdoba, Argentina.

Eduardo Piemonte (E)

Oral Medicine Department, Facultad de Odontología, Universidad Nacional de Córdoba, Córdoba, Argentina.

Nicolás Leonardi (N)

Oral Medicine Department, Dentistry School, Health Sciences Faculty, Universidad Católica de Córdoba, Córdoba, Argentina.

René Panico (R)

Oral Medicine Department, Facultad de Odontología, Universidad Nacional de Córdoba, Córdoba, Argentina.

Saman Warnakulasuriya (S)

Faculty of Dentistry, Oral & Craniofacial Sciences, King's College London, WHO Collaborating Centre for Oral Cancer, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH